OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long Term Metabolic Effects of Sacubitril/Valsartan in Non-Diabetic and Diabetic Patients With Heart Failure Reduced Ejection Fraction: A Real Life Study
Giuseppe Armentaro, Graziella D’Arrigo, Sofia Miceli, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 13
Giuseppe Armentaro, Graziella D’Arrigo, Sofia Miceli, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 13
Showing 13 citing articles:
Effects of SGLT2-Inhibitors on Comprehensive Geriatric Assessment, Biomarkers of Oxidative Stress, and Platelet Activation in Elderly Diabetic Patients with Heart Failure with Preserved Ejection Fraction
Marcello Magurno, Velia Cassano, Francesco Maruca, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8811-8811
Open Access | Times Cited: 6
Marcello Magurno, Velia Cassano, Francesco Maruca, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8811-8811
Open Access | Times Cited: 6
Association between fibrinogen‐to‐albumin ratio and prognosis of patients with heart failure
Qianqian Xu, Chenxi Zhu, Qianqian Zhang, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 10
Closed Access | Times Cited: 10
Qianqian Xu, Chenxi Zhu, Qianqian Zhang, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 10
Closed Access | Times Cited: 10
Metabolic Approaches for the Treatment of Dilated Cardiomyopathy
Roberto Spoladore, Giuseppe Pinto, Francesca Daus, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 7, pp. 287-287
Open Access | Times Cited: 9
Roberto Spoladore, Giuseppe Pinto, Francesca Daus, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 7, pp. 287-287
Open Access | Times Cited: 9
Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure
Velia Cassano, Giuseppe Armentaro, Marcello Magurno, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Velia Cassano, Giuseppe Armentaro, Marcello Magurno, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
Muhammad Nauman Khan, Najia Aslam Soomro, Khalid Naseeb, et al.
BMC Cardiovascular Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Muhammad Nauman Khan, Najia Aslam Soomro, Khalid Naseeb, et al.
BMC Cardiovascular Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
LCZ696 Ameliorates Tachycardia-Induced Cardiac Calcium Dyshomeostasis in the SERCA2<i>α</i>-Dependent Pathway
Lan Liu, Si-Jia Sun, Zhengkai Yang, et al.
The Tohoku Journal of Experimental Medicine (2023) Vol. 260, Iss. 4, pp. 315-327
Open Access | Times Cited: 5
Lan Liu, Si-Jia Sun, Zhengkai Yang, et al.
The Tohoku Journal of Experimental Medicine (2023) Vol. 260, Iss. 4, pp. 315-327
Open Access | Times Cited: 5
Long-Term Treatment With Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction ― Open-Label Extension of the PARALLEL-HF Study ―
Hiroyuki Tsutsui, Shin‐ichi Momomura, Yoshihiko Saito, et al.
Circulation Journal (2023) Vol. 88, Iss. 1, pp. 43-52
Open Access | Times Cited: 5
Hiroyuki Tsutsui, Shin‐ichi Momomura, Yoshihiko Saito, et al.
Circulation Journal (2023) Vol. 88, Iss. 1, pp. 43-52
Open Access | Times Cited: 5
Sacubitril/valsartan promotes white adipose tissue browning in rats with metabolic syndrome through activation of mTORC1
Marina Nikolić, Nevena Jeremić, Nevena Lazarevic, et al.
BioFactors (2024) Vol. 50, Iss. 4, pp. 772-793
Closed Access | Times Cited: 1
Marina Nikolić, Nevena Jeremić, Nevena Lazarevic, et al.
BioFactors (2024) Vol. 50, Iss. 4, pp. 772-793
Closed Access | Times Cited: 1
Effectiveness and Safety of Sacubitril/Valsartan in Heart Failure in India: A Retrospective Real-world (SAVE) Study
Abhishek Sachdeva, Ankit Shukla, Mayur Mayabhate, et al.
Indian Journal of Clinical Cardiology (2024) Vol. 5, Iss. 2, pp. 191-195
Open Access | Times Cited: 1
Abhishek Sachdeva, Ankit Shukla, Mayur Mayabhate, et al.
Indian Journal of Clinical Cardiology (2024) Vol. 5, Iss. 2, pp. 191-195
Open Access | Times Cited: 1
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis
Giuseppe Armentaro, Valentino Condoleo, Corrado Pelaia, et al.
Internal and Emergency Medicine (2022) Vol. 18, Iss. 1, pp. 113-125
Closed Access | Times Cited: 6
Giuseppe Armentaro, Valentino Condoleo, Corrado Pelaia, et al.
Internal and Emergency Medicine (2022) Vol. 18, Iss. 1, pp. 113-125
Closed Access | Times Cited: 6
The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension
Shuang Zhang, Yin Zheng, Zhi-Fan Li, et al.
Cardiovascular Drugs and Therapy (2023)
Closed Access | Times Cited: 2
Shuang Zhang, Yin Zheng, Zhi-Fan Li, et al.
Cardiovascular Drugs and Therapy (2023)
Closed Access | Times Cited: 2
Effects of Sacubitril/Valsartan on Glycemic Control in Japanese Patients With Heart Failure and/or Hypertension
Kahomi Sazawa, Kohei Ohno, Tomohisa Yamashita, et al.
Circulation Reports (2022) Vol. 4, Iss. 12, pp. 588-594
Open Access | Times Cited: 1
Kahomi Sazawa, Kohei Ohno, Tomohisa Yamashita, et al.
Circulation Reports (2022) Vol. 4, Iss. 12, pp. 588-594
Open Access | Times Cited: 1
Heart failure treatment in patients with and without obesity with an ejection fraction below 50%
Yaar Aga, Sumant P. Radhoe, Dilan Aydin, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 7
Open Access
Yaar Aga, Sumant P. Radhoe, Dilan Aydin, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 7
Open Access
